AbbVie To Buy Leukemia Drugmaker Pharmacyclics For $21BAbbVie -- based in North Chicago -- said late Wednesday that it will pay $261.25 a share for Pharmacyclics, which makes Imbruvica, a drug approved to treat three different types of blood cancers. That represents a premium of about 21 percent to the closing price of Pharmacyclics shares on Tuesday.
Chicago Man Blew Whistle On Johnson & Johnson Johnson & Johnson has agreed to pay more than $2 billion to settle some serious criminal and civil charges with the federal government. CBS 2's Jim Williams reports.
Lawsuit: Tylenol Was To Blame For Baby's DeathThe makers of Tylenol are facing a new lawsuit filed by an Illinois family on an old recall.
Self-Published Book Claims Conspiracy In Tylenol PoisoningsNew revelations have surfaced about the origin of the infamous Tylenol poisonings nearly three decades ago.
Study: Drug, Device Help Treat Heart FailureThere's good news for millions of people with mild or moderate heart failure.

More From CBS Chicago

News Via Email
Podcast Network
Free Weather App!

Listen Live